. 2017 Apr-Jun;7(2):119–121. doi: 10.4103/IJCIIS.IJCIIS_100_16
Copyright: © 2017 International Journal of Critical Illness and Injury Science
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Table 2.
Neuroleptic malignant syndrome treatment course
